Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone–deficient children
✍ Scribed by Esteban Mayayo-Sinués; Ana Fanlo; Blanca Sinués; Esteban Mayayo; Jose I. Labarta; Angel García de Jalón; Angel Ferrández-Longás
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 105 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Skinfold thickness (ST) was measured in 43 children with various forms of growth hormone (GH) deficiency during the first year of GH therapy. The average (and SEM) initial ST, expressed as standard deviation score (SDS) was 1.17 (0.25) for subscapular, 0.63 (0.18) for triceps, and 0.40 (0.21) for bi
The growth response during short-term growth hormone (GH) treatment was evaluated in eight prepubertal non-GH-deficient (non-GHD) children and compared with six prepubertal GH-deficient (GHD) patients. Standard doses of GH can improve growth rate in GHD and in some non-GHD patients. In neither group
The effect of glucose on insulin release and the influence of glibenclamide on linear growth were determined in five growth hormone (STH) deficient children who were treated with human growth hormone. It was found that the administration of 5 I.U. of human growth hormone twice a week improved the de